Psyence Biomedical Stock Rockets 130% Pre-Market

Psyence Biomedical leads trending stocks with a stunning 130.26% pre-market surge. Investors pile in on breakthrough news in psychedelics-based medicine. The biotech firm's shares skyrocket amid hype over clinical trials and FDA buzz. Traders watch for volatility as the session opens. Read more about this...